Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma
Modern Pathology2017Vol. 30(12), pp. 1760–1772
Citations Over TimeTop 10% of 2017 papers
Olca Baştürk, Michael F. Berger, Hiroshi Yamaguchi, Volkan Adsay, Gokce Askan, Umesh Bhanot, Ahmet Zehir, Fátima Carneiro, Seung‐Mo Hong, Giuseppe Zamboni, Esra Dikoglu, Vaidehi Jobanputra, Kazimierz O. Wrzeszczyński, Serdar Balcı, Peter J. Allen, Naoki Ikari, Shoko Takeuchi, Hiroyuki Akagawa, Atsushi Kanno, Tooru Shimosegawa, Takanori Morikawa, Fuyuhiko Motoi, Michiaki Unno, Ryota Higuchi, Masakazu Yamamoto, Kyoko Shimizu, Toru Furukawa, David S. Klimstra
Related Papers
- → Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas(2011)434 cited
- → The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes(2016)103 cited
- → Clinical Significance of GNAS Mutation in Intraductal Papillary Mucinous Neoplasm of the Pancreas With Concomitant Pancreatic Ductal Adenocarcinoma(2014)59 cited
- → ID: 3522273 ASSESSING KRAS/GNAS AND BIOLOGIC BEHAVIOR USING MOLECULAR DNA ANALYSIS IN CHARACTERIZING PRE-MALIGNANT PANCREATIC CYSTS(2021)
- → Recognition of GNAS and KRAS mutations in endoscopic ultrasound – fine needle aspiration (EUS-FNA) fluid samples from the main pancreatic duct (MPD) accurately discriminates intraductal papillary mucinous neoplasm (IPMN) from benign conditions with MPD dilatation(2023)